The invention relates to novel methods for production of arginine bicarbonate.
Arginine bicarbonate has use in various industrial applications, including use in personal care compositions, e.g., oral care compositions. See e.g., U.S. Pat. No. 6,524,558. As the industrial requirements for arginine bicarbonate increases, so will the need for improved processes and methods to manufacture the same.
Arginine bicarbonate may be produced by bubbling carbon dioxide gas through a saturated arginine aqueous solution. However, the efficiency of the existing process needs to be improved. The existing process is slow, requiring 24 to 48 hours to complete the reaction. Carbon dioxide has very limited solubility in water, and releasing the gas into the solution produces a maximum concentration of about 1.2×10−5 M at room temperature and its natural partial pressure (3.5×10−4 atmosphere). The solubility of arginine in water is only about 15% weight/weight at room temperature. Producing a concentrated arginine bicarbonate solution (e.g., about 40%) requires the continual addition of arginine to the solution, thereby increasing production time and requires constant monitoring of the reaction. Thus there is a need to improve methods to manufacture arginine bicarbonate.
The present invention is directed to an improved method for manufacturing arginine bicarbonate. The method represents a significant improvement over existing techniques, as a concentrated solution of arginine and bicarbonate anions may be produced in as little as about 10 minutes (vs. about 24-48 hours using the prior art methods), followed by faster and easier recovery processes of arginine bicarbonate salt from the solution since arginine bicarbonate solution at significantly higher concentration. e.g., 60% w/w can be produced.
The present invention includes Method 1.0, a method for producing arginine bicarbonate comprising (i) reacting an arginine slurry with carbon dioxide under controlled temperature and pressure to form a solution comprising arginine and bicarbonate anion, and (ii) optionally recovering arginine bicarbonate from the solution.
Additional methods of the present invention include Methods:
The present invention involves a surprisingly simple reaction to produce arginine bicarbonate salt by reacting carbon dioxide and an arginine slue under controlled temperature and pressure to form an arginine and bicarbonate anion solution, wherein the salt is then recovered from solution. The initial reaction is faster than existing methods, about 10 minutes vs. over 24 hours, and yields a more concentrated solution of arginine and bicarbonate anion (ca. 60% vs. ca. 40%).
The present method begins with the formation of an arginine slurry comprising arginine and a solvent, preferably water. As arginine free base is only slightly soluble at water at room temperature, the addition of arginine to water forms a slurry, wherein a majority of the arginine is insoluble. Any form of arginine may be utilized to form the slurry, e.g., arginine free base (in D or L form, usually L-form), or an arginine salt. It is understood that various arginine salts, e.g., hydrochloride, and pharmaceutically acceptable salts, may be substantially more soluble in water than arginine free base, and this may allow for the production of more concentrated arginine and bicarbonate anion solution. Thus, salts may be used or mixtures of free base and salts may be used in combination to form the slurry.
The slurry is produced by the addition of about 10% to about 90% weight of arginine to the solvent, e.g., about 20% to about 80%, about 30% to about 70%, about 40% to about 60%. The slurry may then be agitated to create a homogenous mixture. The initial pH of the slurry is generally about 12 for arginine free base, e.g., about 10 to about 13.
In one embodiment, the slurry may be heated to about 30° C. to about 80° C., e.g., to about 40° C., to about 50° C., to about 55° C., to about 60° C., to about 65° C., or to about 70° C. to increase the solubility of the arginine.
The reaction between carbon dioxide and water is well known in the art, wherein carbonic acid is initially formed, and disassociates into bicarbonate and hydrogen ions. The bicarbonate then further disassociates into carbonate and an additional hydrogen ion. In the present invention, carbon dioxide is added to the arginine slurry in a pressurized vessel to form bicarbonate anions, resulting in a protonated arginine (cation) and bicarbonate anion solution.
The solubility of carbon dioxide into the slurry may be increased by decreasing the temperature of the solution; however, this decreases the solubility of the arginine. Thus, a careful balance must be maintained between solubility of both components. Thus, in one embodiment, the pressurized vessel may be temperature controlled. The arginine slurry is preferably at a relatively high temperature, e.g. from about 30° C. to about 80° C., when the carbon dioxide is added to the arginine slurry, and thereafter the arginine slurry is permitted to cool to a relatively tow temperature, e.g. from about 0° C. to about 40° C.
One method of decreasing the temperature of the arginine slurry so as to increase the solubility of carbon dioxide into the slurry is to provide the carbon dioxide at a lower temperature than that of the slurry, for example by introducing carbon dioxide as dry ice, or a cooled gas. Preferably, carbon dioxide gas is used in the present reaction. Additionally, direct cooling of the slurry may be carried out.
The solubility of carbon dioxide into the slurry may he increased by increasing the partial pressure of the carbon dioxide in the reaction vessel. Thus, the reaction between the carbon dioxide and the arginine slurry may occur at about 5 psi to about 150 psi, e.g., about 50, to about 60, to about 70, to about 80, to about 90, to about 100, to about 110, to about 120, or to about 140 psi.
The reaction between the arginine slurry and carbon dioxide is then allowed to proceed for about 1 to about 120 minutes. The completion of the reaction may be gauged by monitoring the presence of undissolved arginine in the slurry, as arginine in the presence of bicarbonate anions are highly soluble compared to the arginine slurry. Another method to monitor the reaction is to measure its solution's pH in the reaction vessel directly, or sample the solution and measure its pH in an open container at room temperature.
Depending on the completion of the reaction, preferably, no solid arginine remains, and the arginine and bicarbonate anion solution is clear and colorless, additional carbon dioxide may be added to the reaction vessel.
Following the production of the arginine bicarbonate solution, the arginine bicarbonate salt may be recovered by any means known by those of skill in the art. In one embodiment, the solvent is evaporated, e.g., by heating, spray drying, or freeze drying. In another embodiment, the salt is precipitated from solution by the addition of alcohol.
The present methods may be utilized to produce arginine bicarbonate in single hatches, or may be used in a continuous process, such as in continuous stirred tank reactors, fluidized bed reactors, and plug flow reactors.
As used throughout, ranges are used as shorthand for describing each and every value that is within the range. Any value within the range can be selected as the terminus of the range. In addition, all references cited herein are hereby incorporated by reference in their entireties. In the event of a conflict in a definition in the present disclosure and that of a cited reference, the present disclosure controls. It is understood that when formulations are described, they may be described in terms of their ingredients, as is common in the art, notwithstanding that these ingredients may react with one another in the actual formulation as it is made, stored and used, and such products are intended to be covered by the formulations described.
The following examples further describe and demonstrate illustrative embodiments within the scope of the present invention. The examples are given solely for illustration and are not to be construed as limitations of this invention as many variations are possible without departing from. the spirit and scope thereof. Various modifications of the invention in addition to those shown and described herein should be apparent to those skilled in the art and are intended to fall within the appended claims.
A slurry of pH 12 containing 50% L-arginine by weight and 50% water by weight is prepared by mixing 85 g of L-arginine with 85 g of water at room temperature. The slurry is heated to 55° C. under gentle agitation. Approximately 50% of the L-arginine is determined to be dissolved by visual observation.
25 grams of dry ice particles are added to the slurry produced in EXAMPLE 1, and the mixture is transferred to a pressurized vessel. The dry ice is allowed to sublime in order to purge atmospheric air from the vessel, and then the vessel is sealed. Pressure in the vessel is allowed to increase to 80 psi, and the solution is maintained under pressure for 3 minutes. The vessel is opened, a small amount of unreacted arginine is observed at the bottom of the vessel.
The solution of EXAMPLE 2 is stirred with a spatula to make a suspension. 10 grams of dry ice is added to the vessel, and the vessel is sealed. The pressure is allowed to increase to, and maintained at 90 psi. The vessel is opened after 3 minutes, and a thick clear colorless solution is observed without precipitation. The solution has dropped to 12° C. producing an arginine bicarbonate solution of about 60% concentration, and a final pH of 8.79. Arginine bicarbonate salt is recovered by freeze drying.
The slurry produced in EXAMPLE 1 is transferred to a pressurized vessel, and aerated with carbon dioxide gas to obtain a carbon dioxide partial pressure of 15 psi for 5 minutes. The temperature of the reactants is lowered to 10° C. An arginine bicarbonate anion solution is formed, and arginine bicarbonate salt is recovered by spray drying.
This application claims the benefit of U.S. Ser. No. 61/027,433 filed Feb. 8, 2008, the contents of which are incorporated herein by reference.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2009/033293 | 2/6/2009 | WO | 00 | 8/6/2010 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2009/100267 | 8/13/2009 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3925543 | Donohue | Dec 1975 | A |
3932605 | Vit | Jan 1976 | A |
3932608 | Anderson et al. | Jan 1976 | A |
3943241 | Anderson et al. | Mar 1976 | A |
3988434 | Schole et al. | Oct 1976 | A |
4011309 | Lutz | Mar 1977 | A |
4022880 | Vinson et al. | May 1977 | A |
4025616 | Haefele | May 1977 | A |
4042680 | Muhler et al. | Aug 1977 | A |
4064138 | Saari et al. | Dec 1977 | A |
4100269 | Pader | Jul 1978 | A |
4108979 | Muhler et al. | Aug 1978 | A |
4108981 | Muhler et al. | Aug 1978 | A |
4146607 | Ritchey | Mar 1979 | A |
4154813 | Kleinberg | May 1979 | A |
4160821 | Sipos | Jul 1979 | A |
4213961 | Curtis et al. | Jul 1980 | A |
4225579 | Kleinberg | Sep 1980 | A |
4259316 | Nakashima et al. | Mar 1981 | A |
4269822 | Pellico et al. | May 1981 | A |
4305928 | Harvey | Dec 1981 | A |
4335102 | Nakashima et al. | Jun 1982 | A |
4339432 | Ritchey et al. | Jul 1982 | A |
RE31181 | Kleinberg et al. | Mar 1983 | E |
4466954 | Ichikawa et al. | Aug 1984 | A |
4528181 | Morton et al. | Jul 1985 | A |
4532124 | Pearce | Jul 1985 | A |
4538990 | Pashley | Sep 1985 | A |
4645662 | Nakashima et al. | Feb 1987 | A |
4656031 | Lane et al. | Apr 1987 | A |
4725576 | Pollock et al. | Feb 1988 | A |
4885155 | Parran et al. | Dec 1989 | A |
4919910 | Kurtz et al. | Apr 1990 | A |
4997640 | Bird et al. | Mar 1991 | A |
5096700 | Siebel et al. | Mar 1992 | A |
5286480 | Boggs et al. | Feb 1994 | A |
5334617 | Ulrich et al. | Aug 1994 | A |
5370865 | Yamagishi et al. | Dec 1994 | A |
5639795 | Friedman et al. | Jun 1997 | A |
5747004 | Giani et al. | May 1998 | A |
5762911 | Kleinberg et al. | Jun 1998 | A |
5906811 | Hersh | May 1999 | A |
5922346 | Hersh | Jul 1999 | A |
5997301 | Linden | Dec 1999 | A |
6217851 | Kleinberg et al. | Apr 2001 | B1 |
6436370 | Kleinberg et al. | Aug 2002 | B1 |
6488961 | Robinson et al. | Dec 2002 | B1 |
6524558 | Kleinberg et al. | Feb 2003 | B2 |
6558654 | McLaughlin | May 2003 | B2 |
6805883 | Chevaus et al. | Oct 2004 | B2 |
6890497 | Rau et al. | May 2005 | B2 |
20020081360 | Burgard et al. | Jun 2002 | A1 |
20030215513 | Fyhr et al. | Nov 2003 | A1 |
20060193791 | Boyd et al. | Aug 2006 | A1 |
20070154863 | Cai et al. | Jul 2007 | A1 |
20080233054 | Kleinberg et al. | Sep 2008 | A1 |
20090202456 | Prencipe et al. | Aug 2009 | A1 |
Number | Date | Country |
---|---|---|
1736135 | Dec 1996 | EP |
1135110 | Sep 2001 | EP |
WO9641617 | Dec 1996 | WO |
WO 97032565 | Sep 1997 | WO |
WO 00078270 | Dec 2000 | WO |
WO2007008908 | Jan 2007 | WO |
WO 09099451 | Aug 2009 | WO |
WO 09100267 | Aug 2009 | WO |
WO 09100278 | Aug 2009 | WO |
Entry |
---|
US 5,989,525, 11/1999, Kleinberg et al. (withdrawn) |
AminoScience L-Arginine recovered from http://www.ajinomoto.co.jp/kfb/amino/e—aminoscience/bc/amino—02.html 30 on Mar. 30, 2012. |
Machado et al. CaviStat Confection Inhibition of Caries in Posterior Teeth, Abstract, 83rd Session of the American Association for Dental Research, Mar. 21-24, 2007, New Orleans, LA. |
Chatterjee et al,. Bacterial Acidification and CaviStat Alkalinization of Occlusal Fissure pH, Abstract, 83rd Session of the American Association for Dental Research, Mar. 9-12, 2005, Baltimore, MD. |
Kleinberg I., A Mixed-Bacteria Ecological Approach to Understanding the Role of the Oral Bacteria in Dental Caries Causation: An Alternative to Streptococcus Mutans and the Specific-Plaque Hypothesis, CRIT. Rev. Oral Biol. Med,. 12(2): 108-125 (2002). |
Kleinberg I., A New Salvia-Based Anticaries Composition, Dentistry Today, vol. 18, No. 2, Feb. 1999. |
Acevedo et al., “The Inhibitory effect of an arginine bicarbonate/calcium carbonate (CaviStat)—containing dentifrice on the development of dental caries in Venezuelean school children”, The Journal of clinical Dentistry, 2005, v. 16, No. 3, pp. 63-70, ISSN 0895-8831. |
International Search Report and Written Opinion in International Application No. PCT/US09/033293, mailed Jun. 24, 2009. |
International Search Report and Written Opinion in International Application No. PCT/US10/059992, mailed May 18, 2011. |
International Search Report and Written Opinion in International Application No. PCT/US10/060266, mailed Mar. 14, 2011. |
Packaging with ingredient list for DenClude® (launched Dec. 2004). |
Packaging with ingredient list for ProClude® (launched Jul. 2002). |
Written Opinion in International Application No. PCT/US10/059992, mailed Nov. 16, 2011. |
Number | Date | Country | |
---|---|---|---|
20120088930 A1 | Apr 2012 | US |
Number | Date | Country | |
---|---|---|---|
61027433 | Feb 2008 | US |